The shares of OncoCyte Corporation (NYSE:OCX) has been pegged with a rating of Buy by Janney in its latest research note that was published on January 29th, 2019. Janney wasn’t the only research firm that published a report of OncoCyte Corporation, with other equities research analysts also giving their opinion on the stock. Lake Street advised investors in its research note published on December 19th, 2018, to Buy the OCX stock.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 0 believe it has the potential for further growth, thus rating it as Hold while 2 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $7.44. The price of the stock the last time has raised by 263.64% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 59.86.
The shares of the company dipped by -6.98% during the trading session on Friday, reaching a low of $3.81 while ending the day at $4.00. During the trading session, a total of 4.54 million shares were traded which represents a -344.87% decline from the average session volume which is 1.02M shares. OCX had ended its last session trading at 4.30. OncoCyte Corporation currently has a market cap of $174.92M. OncoCyte Corporation debt-to-equity ratio currently stands at 0.28, while its quick ratio hovers at 2.60. OCX 52-week low price stands at $1.10 while its 52-week high price is $6.92.
OncoCyte Corporation has the potential to record -0.44 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Keefe Bruyette published a research note on January 14th, 2019 where it informed investors and clients that AGNC Investment Corp. (NASDAQ:AGNC) is now rated as Outperform. Lake Street also rated AGNC as Resumed on December 19th, 2018, with its price target of $380 suggesting that AGNC could down by 0% from its current share price. Even though the stock has been trading at $17.85/share, analysts expect it to surge higher by -0.22% to reach $17.81/share. It started the day trading at $17.86 and traded between $17.68 and $17.81 throughout the trading session.
A look at its technical shows that AGNC’s 50-day SMA is 17.82 while its 200-day SMA stands at 18.48. The stock has a high of $19.72 for the year while the low is $16.96. The company’s P/E ratio currently sits at 29.88, while the P/B ratio is 0.90. The company’s average trading volume currently stands at 7.29M shares, which means that the short-interest ratio is just 1.63 days. Over the past seven days, the company moved, with its shift of 0.28%. Looking further, the stock has raised 0.11% over the past 90 days while it lost -5.67% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more AGNC shares, increasing its portfolio by +13.93% during the last quarter. This move now sees The Vanguard Group Inc purchasing 4,981,630 shares in the last quarter, thus it now holds 40,752,823 shares of AGNC, with a total valuation of $714,804,515. BlackRock Fund Advisors meanwhile bought more AGNC shares in the recently filed quarter, changing its stake to $622,329,970 worth of shares. Michigan Department of Treasury followed the path by increasing its AGNC portfolio by +5.91% in the quarter. This means that Michigan Department of Treasury bought 1,330,000 shares in the last quarter and now controls 23,815,845 shares of the AGNC stock, with the valuation hitting $417,729,921.
Similarly, SSgA Funds Management Inc increased its AGNC Investment Corp. shares by +14.15% during the recently filed quarter. After buying 1,849,584 shares in the last quarter, the firm now controls 14,921,639 shares of AGNC Investment Corp. which are valued at $261,725,548. In the same vein, Nan Shan Life Insurance Co Ltd decreased its AGNC Investment Corp. shares by during the most recent reported quarter. The firm sold -960,688 shares during the quarter which decreased its stakes to 10,427,925 shares and is now valued at $182,905,805. Following these latest developments, around 0.40% of AGNC Investment Corp. stocks are owned by institutional investors and hedge funds.